The dysfibrinogenaemias

British Journal of Haematology

Volumn 114, Issue 2, 2001, Pages 249-257

  Roberts, Harold R ^a   Stinchcombe, Thomas E ^a   Gabriel, Don A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bleeding; Dysfibrinogenaemia; Fibrinogen; Genetic mutations; Thrombosis

Indexed keywords

BLEEDING TENDENCY; DISEASE ASSOCIATION; DYSFIBRINOGENEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBIN TIME; THROMBOSIS;

AFIBRINOGENEMIA; BLOOD COAGULATION TESTS; CARCINOMA, HEPATOCELLULAR; FIBRINOGEN; HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MUTATION; THROMBOSIS;

EID: 0034889425     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02892.x     Document Type: Review

References (46)

1. Fibrinogen 'New York' - An abnormal fibrinogen associated with thromboembolism: Functional evaluation
2. The fibrinogen sequences that interact with thrombin
3. A two-step fibrinogen-fibrin transition in blood coagulation
4. Size and density of fibrin fibers from turbidity
5. A physical standard of fibrinogen: Measurement of the elastic modulus of dilute fibrin gels with a new elastometer
6. Inhibition of fibrin monomer polymerization by lambda myeloma globulins
7. Metabolism and distribution of fibrinogen
8. Gamma-chain dysfibrinogenemias: Molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen
9. Crosslinking of monomeric fibrin by factor XIIIa
10. Fibrinogen and fibrin
11. A three-dimensional consideration of variant human fibrinogens
12. Cellular site of fibrinogen synthesis
13. Translational and cotranslational events in fibrinogen synthesis
14. The influence of immunoglobulin (IgG) on the assembly of fibrin gels
15. The effect of fibrin structure on fibrinolysis
16. Monoclonal IgG anticoagulants delaying fibrin aggregation in two patients with systemic lupus erythematous (SLE)
17. 308→Lys) does not affect the binding of t-PA and plasminogen to fibrin
18. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule
19. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting
20. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SCC Subcommittee on Fibrinogen
21. The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2
22. Covalent structure of fibrinogen
23. Dextran and hydroethyl starch interfere with fibrinogen assays
24. The role of amino-terminal disulfide bonds in the structure and assembly of human fibrinogen
25. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala→Thr
26. Transient intermediates in the thrombin activation of fibrinogen. Evidence for only the desAA species
27. Fibrinogen Bellingham: A gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family
28. Characterization of fibrinogen New York I. A dysfunctional fibrinogen with a deletion of B beta (9-72) corresponding exactly to exon 2 of the gene
29. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads
30. Fibrinogen, chapter 3
31. Fibrinogen Lima: A homozygous dysfibrinogen with an A α-arginine-141 to serine substitution associated with extra N-glycosylation at A α-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator
32. Acquired coagulation inhibitor delaying fibrinopeptide release
33. The abnormal carbohydrate composition of the dysfibrinogenemia associated with liver disease
34. Dysfibrinogenemia and other disorders of fibrinogen structure and function, chapter 53
35. Dysfibrinogenemia and thrombosis
36. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils
37. Fibrinopeptide B in fibrin assembly and metabolism: Physiologic significance in the delayed release of the peptide
38. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis
39. Fibrinogens Bern IV, Bern V and Milano XI: Three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the A alpha-chain
40. Factor XIIIa cross-linking of the Marburg fibrin: Formation of alpha gamma-heteromultimers and the alpha-chain-linked albumin-gamma complex, and disturbed protofibril assembly resulting in acquisition of plasmin resistance relevant to thrombophilia
41. A correlation between thrombotic disease and a specific fibrinogen abnormality (A alpha 544 Arg_Cys) in two unrelated kindred. Dusart and Chapel Hill III
42. A new type of congenital dysfibrinogen, fibrinogen Bremen, associated with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing
43. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides
44. A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi
45. A new congenital abnormal fibrinogen Ise characterized by the replacement of the B beta glycine-15 by cysteine